Fuente y mas informacion:
Myeloma Minute - January 26, 2009
http://readtheminute.myeloma.org/
SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
http://bloodjournal.hematologylibra.../113/4/846?etoc
Yutaka Okawa, Teru Hideshima, Paul Steed, Sonia Vallet, Steven Hall, Ken Huang, John Rice, Amy Barabasz, Brianna Foley, Hiroshi Ikeda, Noopur Raje, Tanyel Kiziltepe, Hiroshi Yasui, Sotaro Enatsu, and Kenneth C. Anderson*
Blood 2009;113 846-855
ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype
http://bloodjournal.hematologylibra...73914v1?papetoc
Alessandra Soriani, Alessandra Zingoni, Cristina Cerboni, Maria Luisa Iannitto, Maria Rosaria Ricciardi, Valentina Di Gialleonardo, Marco Cippitelli, Cinzia Fionda, Maria Teresa Petrucci, Anna Guarini, Robin Foa, and Angela Santoni
Blood published 19 December 2008, 10.1182/blood-2008-08-173914
The yin and yang of lenalidomide
http://bloodjournal.hematologylibra...12/13/4785?etoc
Neil E. Kay
Blood 2008;112 4785-4786
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
http://bloodjournal.hematologylibra...12/13/4924?etoc
David C. Johnson, Sophie Corthals, Christine Ramos, Antje Hoering, Kim Cocks, Nicholas J. Dickens, Jeff Haessler, Harmut Goldschmidt*, J. Anthony Child*, Sue E. Bell, Graham Jackson, Dalsu Baris*, S. Vincent Rajkumar*, Faith E. Davies*, Brian G. M. Durie*, John Crowley*, Pieter Sonneveld*, Brian Van Ness*, and Gareth J. Morgan*
Blood 2008;112 4924-4934
Note: This is a Bank On A Cure? Study
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
http://bloodjournal.hematologylibra...12/13/5095?etoc
Erik A. Nelson, Sarah R. Walker, Alicia Kepich, Laurie B. Gashin, Teru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, Kenneth C. Anderson*, and David A. Frank
Blood 2008;112 5095-5102
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia
http://bloodjournal.hematologylibra...12/13/5111?etoc
Sophia Adamia, Amanda A. Reichert, Hemalatha Kuppusamy, Jitra Kriangkum, Anirban Ghosh, Jennifer J. Hodges, Patrick M. Pilarski, Steven P. Treon, Michael J. Mant, Tony Reiman, Andrew R. Belch, and Linda M. Pilarski*
Blood 2008;112 5111-5121
Non-myeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo
http://bloodjournal.hematologylibra...67379v1?papetoc
Benedetto Bruno, Marcello Rotta, Francesca Patriarca, Daniele Mattei, Bernardino Allione, Fabrizio Carnevale-Schianca, Roberto Sorasio, Alessandro Rambaldi, Marco Casini, Matteo Parma, Pasqua Bavaro, Francesco Onida, Alessandro Busca, Luca Castagna, Edoardo Benedetti, Anna Paola Iori, Luisa Giaccone, Antonio Palumbo*, Paolo Corradini, Renato Fanin, David
Maloney, Rainer Storb, Ileana Baldi, Umberto Ricardi, and Mario Boccadoro*
Blood published 8 December 2008, 10.1182/blood-2008-07-167379
A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97
http://www.sciencedirect.com/scienc...c9f80ce20c25d21
David H. Vesole*, Lijun Zhang, Neal Flomenberg, Philip R. Greipp, Hillard M. Lazarus and for the ECOG Myeloma and BMT Committees
(Biol Blood Marrow Transplant) doi:10.1016/j.bbmt.2008.10.030
____________
Un saludo
Victor Quesada
Webmaster y Administrador de Mieloma.com
Guia de Uso -
http://www.mieloma.com/ayuda/
Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.